Arpita Roychowdhri*, Abhijit Tarafdar**
DM Senior Resident,Department of Nephrology, IPGMER, Kolkata. *, Professor & Head Department of Nephrology, IPGMER, Kolkata.**
SLE nephritis is being reported even at <2 yrs of age with a poor prognosis. Prevalence of pediatric SLE is 15% and it is more common among Asians, native Americans, blacks and Polynesians. Lupus nephritis is observed in all most all children with SLE. To begin with, severe nephritis initially may not be associated any changes in creatinine clearance, proteinuria or abnormal urinary sediment. Renal biopsy is essential in lupus nephritis for prognostication and therapeutic intervention. Outcome is poorest in class IV lupus nephritis and best in children with minimal or controlled systemic disease. Management of pediatric SLE nephritis includes good induction therapy to prevent flare and avoidance of renal damage, improvement of patient's QOL and psychosocial development. This is achieved with standard immuno-suppresives like cyclophosphamide, corticosteriod, azothioprine, hydroxychloroquine, cyclosporine & MMF. Standard protocols for treatment of lupus nephritis are not much different from adult nephritis management. The present survival rate is 94%.
How to Cite URL :
Roychowdhri A, Tarafdar A.. Available From : Conference_abstracts/report.aspx?reportid=103
Disclaimer: The information given by is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.